Have a personal or library account? Click to login
Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism Cover

Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism

By: I. Yankova,  A. Shinkov and  R. Kovatcheva  
Open Access
|Apr 2022

References

  1. 1. Wermers RA, Khosla S, Аtkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J. Bone Miner Res 2006; 21(1):171-7.10.1359/JBMR.05091016355286
  2. 2. Udelsman R Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002; 235(5):665-670.10.1097/00000658-200205000-00008142249211981212
  3. 3. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011; 253(3):585-591.10.1097/SLA.0b013e318208fed921183844
  4. 4. Thomas DC, Roman SA, Sosa JA. Parathyroidectomy in the elderly: analysis of 7313 patients. J Surg Res 2011; 170:240-246.10.1016/j.jss.2011.03.01421571309
  5. 5. Iñiguez-Ariza NM, Lee RA, Singh-Ospina NM, et al. Ethanol Ablation for the Treatment of Cystic and Predominantly Cystic Thyroid Nodules. Mayo Clin Proc. 2018; 93(8):1009-1017.10.1016/j.mayocp.2018.05.02030078409
  6. 6. Sharma A, Abraham D. Vascularity targeted percutaneous ethanol injection of toxic adenomas: outcomes of a feasibility study performed in the USA. Endocr Pract. 2020; 26(1):22-29.10.4158/EP-2019-032931461356
  7. 7. Hay ID, Lee RA, Kaggal S, et al. Long-term results of treating with ethanol ablation 15 adult patients with cT1aN0 papillary thyroid microcarcinoma, J Endocr. Soc. 2020; 4(11):1-9.
  8. 8. Bhatti AH, Sheikh AE, Mahmud US, et. al. Clinical profile and treatment of hepatocellular carcinoma: A single-center experience. South Asian J Cancer 2021; 10:76-80.10.1055/s-0041-1729451846034134568219
  9. 9. Solbiati L, Giangrande A, De-Pra L, et al. Percutaneous ethanol injection of parathyroid tumours under US guidance: treatment of secondary hyperthyroidism. Radiol 1985; 155:607-10.10.1148/radiology.155.3.38899993889999
  10. 10. Kovatcheva R, Borissova A-M, Kanev N, et al. Ultrasoundguided percutaneous sclerosing of parathyroid glands - an alternative to complex treatment of secondary hyperparathyroidism. Rеntgenologiya I Radiologiya 1994; 33(4):33.
  11. 11. Fletcher S, Kanagasundaram NS, Rayner HC, et al. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 1998; 13:3111-3117.10.1093/ndt/13.12.31119870475
  12. 12. Koiwa F, Kakuta T, Tanaka R, Yumita S. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2007; 22:522-8.10.1093/ndt/gfl62017127701
  13. 13. Charboneau JW, Hay ID, Van Heerden JA. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc 1988; 63:913-7.10.1016/S0025-6196(12)62695-0
  14. 14. Harman CR, Grant CS, Hay ID, et al. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 1998; 124:1011-9.10.1067/msy.1998.91826
  15. 15. Kovatcheva R, Vlahov J, Shinkov A, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: A feasibility study in four patients. Am J Roentgenol, 2010, 195(4): 830-835.10.2214/AJR.09.3932
  16. 16. Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided highintensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol, 2014, 24(9): 2052-2058.10.1007/s00330-014-3252-4
  17. 17. Fan BQ, He XW, Chen HH, Zhang WM, Tang W. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur Radiol, 2019; 29 (10):5607-5616.10.1007/s00330-019-06078-y
  18. 18. Kim BS, Eom TI, Kang KH, Park SJ. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrason, 2014; 41(2):239-43.10.1007/s10396-013-0501-0
  19. 19. Cercueil JP, Jacob D, Verges B, et al. Percutaneous ethanol injection into parathyroid adenomas: Mid and longterm results. Eur Radiol 1998; 8:15659.10.1007/s003300050587
  20. 20. Stratigis S, Stylianou K, Mamalaki E, et al. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008; 69:542-8.10.1111/j.1365-2265.2008.03238.x
  21. 21. Yazdani АА, Khalili N, Siavash M, et al. Ultrasoundguided ethanol injection for the treatment of parathyroid adenoma: A prospective selfcontrolled study, J Res Med Sci 2020; 25:93.
  22. 22. Chen HH, Hsu MT, Wu CJ, et al. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy. Am J Surg 2008;196:155-9.10.1016/j.amjsurg.2007.06.037
  23. 23. Verges B, Cercueil JP, Pfitzenmeyer P, et al. Percutaneous ethanol injection of parathyroid adenomas in primary hyperparathyroidism. Lancet 1991; 337: 1421-2.10.1016/0140-6736(91)93115-P
  24. 24. Karstrup S, Transbol I, Holm H, et al. Ultrasound-guided chemical parathyroidectomy in patients with primary hyperthyroidism: a prospective study. Br J Radiol 1989; 62 1037-42.10.1259/0007-1285-62-744-10372691006
  25. 25. Veldman MW, Reading CC, Farrell MA, et al. Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. Am J Roentgenol 2008; 191:1740–4.10.2214/AJR.07.343119020245
  26. 26. Cappelli C, Pelizzari G, Pirola I, et al. Modified percutaneous ethanol injection of parathyroid adenoma in primary hyperparathyroidism. QJM 2008; 101(8):657-62.10.1093/qjmed/hcn06218499732
DOI: https://doi.org/10.2478/amb-2022-0001 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 5 - 11
Submitted on: Jan 1, 2022
Accepted on: Jan 6, 2022
Published on: Apr 22, 2022
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 I. Yankova, A. Shinkov, R. Kovatcheva, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.